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Table 1. Clinical Presentaiton of AML 2-4
 
•	Pancytopenia complications
							•	Anemia: fatigue, weakness, skin pallor
							•	Thrombocytopenia: gingival bleeding, ecchymosis, epistaxis, petechiae
							•	Leukopenia: varying degrees of infections
•	Extramedullary sites
							•	Gingival infiltrates
							•	Cutaneous lesions: vasculitis, Leukemia Cutis
							•	Myeloid sarcoma: intestines, mediastinum, uterus, ovary, lymph nodes, orbit
•	Bone Pain/Arthralgias
•	CNS involvement: headache, facial nerve palsies, motor deficits
•	Fever: infection > leukemia
•	Adenopathy: palpable and significant enlargement is rare
•	Organomegaly
•		A	59	year-old-female	presents	with	generalized weakness, low grade fevers and weight loss	over	2	
months	with	bilateral	ankle	arthralgias	and	maculopapular, nonpruritic rash on abdomen	(Image	1)	
developing	after	~1.5	months.		 

















			 	 –	 	LC	is	more	common	in	systemic	disease,	occurring	aleukemic	in	7%.5




			 	 –	 	LC	represent	aggressive	disease,	higher	tumor	burden	with	poor	
prognosis,	but	shorter	time	to	remission.7-9
			 	 –	 	Increase	risk	for	relapse	and	new	skin	lesions	require	re-biopsy.9




			 	 –	 	Stem	cell	transplant	considered	in	first	remission	with	other	prognostic	
factors.9
			 	 –	 	Chemotherapy	may	induce	remission	in	bone	marrow	but	not	with	
LC.9
			 	 –	 	Palliative	radiation	can	help	with	pruritus.9
Table 2. Leukemia Cutis Characteristics5,7-9
Size/Shape Color Distribution
Macules  Solitary Red Lower Extremity
Papules Multiple Brown Upper Extremity
Plaques  Violaceous Trunk/Face
Nodules  Blueberry (infants)
Ulcers
•	Areas of inflammation/trauma
•	Physiologic response to specific chemotactic factors
  
Image 1. Maculopapular,	
erythematous/violaceous,	non-
pruritic	rash	that	erupted	gradually	
on	patient	abdomen	and	back	prior	
to	spreading	to	the	extremities.	
Rash	did	not	improve	with	systemic	
steroids	but	resolved	with	7+3	
induction	chemotherapy.	
Image 2. Peripheral	blood	smear	
shows	large	amount	of	mature	
monocytes	with	no	evidence	of	
dysplasia	(A).		Smear	was	taken	same	
time	as	skin	biopsy.	Flow	cytometry	
indicates	the	large	monocyte	
population	(B).
Image 3. Skin	biopsy	shows	monocytic	infiltrate	
consistent	with	leukemia	cutis	with	the	dermis	
exhibiting	overwhelming	immature	monocytic	
infiltrates	positive	for	MPO,CD68,	CD45,	CD33,	
CD68,	CD4.	Biopsy	was	performed	after	3	
weeks	of	maculopapular	rash	present	with	a	
peripheral	blood	smear	that	showed	only	mature	
monocytosis.	
Image 4. Bone	marrow	biopsy	with	82%	monoblasts	
with	diminished	maturation.	+CD56	and	–CD117	
assist	with	the	M5	AML	diagnosis.	+FLT3	ITD,	NPM1	
and	–	CEBPA,	confirming	with	a	poor	prognosis	and	
aggressive	disease.		
AML	should	be	suspected	in	
patients	presenting	with	skin	
lesions,	low	grade	fevers,	weight	
loss	and	leukocytosis	despite	lack	
of	leukemic	cells	in	peripheral	
blood.	Treatment	should	not	be	
delayed	and	initiated	based	on	
skin	biopsy.
Conclusion:
